Androgen Receptor-Target Genes in African American Prostate Cancer Disparities
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Prostate Cancer
- Vol. 2013, 1-15
Abstract
The incidence and mortality rates of prostate cancer (PCa) are higher in African American (AA) compared to Caucasian American (CA) men. To elucidate the molecular mechanisms underlying PCa disparities, we employed an integrative approach combining gene expression profiling and pathway and promoter analyses to investigate differential transcriptomes and deregulated signaling pathways in AA versus CA cancers. A comparison of AA and CA PCa specimens identified 1,188 differentially expressed genes. Interestingly, these transcriptional differences were overrepresented in signaling pathways that converged on the androgen receptor (AR), suggesting that the AR may be a unifying oncogenic theme in AA PCa. Gene promoter analysis revealed that 382 out of 1,188 genes containedcis-acting AR-binding sequences. Chromatin immunoprecipitation confirmedSTAT1, RHOA, ITGB5, MAPKAPK2, CSNK2A,1andPIK3CBgenes as novel AR targets in PCa disparities. Moreover, functional screens revealed that androgen-stimulated AR binding and upregulation ofRHOA, ITGB5,andPIK3CBgenes were associated with increased invasive activity of AA PCa cells, as siRNA-mediated knockdown of each gene caused a loss of androgen-stimulated invasion. In summation, our findings demonstrate that transcriptional changes have preferentially occurred in multiple signaling pathways converging (“transcriptional convergence”) on AR signaling, thereby contributing to AR-target gene activation and PCa aggressiveness in AAs.Keywords
Funding Information
- American Cancer Society (IRG-08-091-01 (BDW), U01 CA116937 (SRP), R01 CA120316 (NHL))
- National Cancer Institute (IRG-08-091-01 (BDW), U01 CA116937 (SRP), R01 CA120316 (NHL))
- National Cancer Institute (IRG-08-091-01 (BDW), U01 CA116937 (SRP), R01 CA120316 (NHL))
This publication has 94 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- A transcriptional repressor co‐regulatory network governing androgen response in prostate cancersThe EMBO Journal, 2012
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesisThe EMBO Journal, 2011
- Molecular basis of a novel oncogenic mutation in GNAO1Oncogene, 2011
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesisNature, 2008
- Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancersOncogene, 2008
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001